|
Q2 FY2026
As of Jun 30, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q1 FY2026
As of Mar 31, 2026
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Funds held in trust | ||||||||||||||||||||
| Accrued receivables | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Government remittances receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Trade receivables | ||||||||||||||||||||
| Prepaid expenses and deposits | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Long-lived Assets, net | ||||||||||||||||||||
| Long-lived Assets held for sale | ||||||||||||||||||||
| Long-Term Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIENCY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable-related parties | ||||||||||||||||||||
| Government remittances payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued liabilities-related parties | ||||||||||||||||||||
| Current portion of long-term debt-in default | ||||||||||||||||||||
| Current portion of obligations under capital lease | ||||||||||||||||||||
| Convertible Debt | ||||||||||||||||||||
| Convertible promissory notes-in default | ||||||||||||||||||||
| Loans payable to related parties | ||||||||||||||||||||
| Loans payable to related parties | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Obligations under capital lease | ||||||||||||||||||||
| Total Long-term Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Deficiency | ||||||||||||||||||||
| Preferred stock, $.0001 par value, 10,000,000 authorized, none issued and outstanding | ||||||||||||||||||||
| Common stock, $.0001 par value, 150,000,000 authorized, 142,332,019 (2025- 142,332,019) shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Shares to be issued | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Stockholders' deficiency | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficiency | ||||||||||||||||||||
Loading...
